Ezetimibe combined with standard diet and exercise therapy improves insulin resistance and atherosclerotic markers in patients with metabolic syndrome

AIMS/INTRODUCTION: Ezetimibe lowers serum lipid levels by inhibiting intestinal absorption of dietary and biliary cholesterol. However, the effect of ezetimibe on insulin resistance remains unclear. The aim of the present study was to examine this issue in patients with metabolic syndrome in local-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohbu-Murayama, Kyoko, Adachi, Hisashi, Hirai, Yuji, Enomoto, Mika, Fukami, Ako, Obuchi, Aya, Yoshimura, Ayako, Nakamura, Sachiko, Nohara, Yume, Nakao, Erika, Umeki, Yoko, Fukumoto, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420565/
https://www.ncbi.nlm.nih.gov/pubmed/25969718
http://dx.doi.org/10.1111/jdi.12298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420565/
https://www.ncbi.nlm.nih.gov/pubmed/25969718
http://dx.doi.org/10.1111/jdi.12298

Ejemplares similares